Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 30060024.
- Also identified by DOI 10.1093/cid/cix523 and PMC identifier 5848255.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
NCT01241552 (MODIFY I) and NCT01513239 (MODIFY II).
Medical subject headings
- Anti-Bacterial Agents
- Antibodies, Monoclonal
- Antibodies, Neutralizing
- Clostridioides difficile
- Clostridium Infections